What is Silver Creek Pharmaceuticals worth?
$60.0Mlast known valuation
Silver Creek Pharmaceuticals last raised $9.2M in its Early Stage VC (Jan 2022).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Silver Creek Pharmaceuticals
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2022 | Early Stage VC | $9.2M | ▮ | ▮ |
| Dec 2016 | Seed Round | $3.4M | ▮ | ▮ |
How Silver Creek Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Silver Creek Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Silver Creek Pharmaceuticals worth?
- Silver Creek Pharmaceuticals's last known valuation is $60.0M.
- How much has Silver Creek Pharmaceuticals raised?
- Silver Creek Pharmaceuticals has raised $57.1M in total funding across 2 recorded rounds.
- When did Silver Creek Pharmaceuticals last raise?
- Silver Creek Pharmaceuticals last raised in Jan 2022 (Early Stage VC), raising $9.2M.